HERON THERAPEUTICS INC (HRTX)
US4277461020 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 86.3M -2.60% | 107.7M 24.80% | 127.044M 17.96% | 143.69M 13.10% | 170.65M 18.76% | 193.9M 13.62% | 221.6M 14.29% | 250.51M 13.05% | 277.13M 10.63% | 307.63M 11.01% | 314.06M 2.09% | |
| EBITDA YoY % growth | -214.78M 4.69% | -171.81M 20.01% | -107.716M 37.31% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -217.8M 4.56% | -174.7M 19.79% | -110.615M 36.68% | -19.584M 82.30% | -3.995M 79.60% | 20.706M 618.30% | 43.401M 109.61% | 67.932M 56.52% | 78.438M 15.47% | 101.39M 29.26% | 100.06M -1.31% | |
| Operating Margin | -252.38% | -162.21% | -87.07% | -13.63% | -2.34% | 10.68% | 19.59% | 27.12% | 28.30% | 32.96% | 31.86% | |
| EPS YoY % growth | -2.25 10.00% | -1.73 23.11% | -0.86 50.29% | -0.13 85.37% | -0.03 75.68% | 0.13 533.33% | 0.35 161.54% | 0.44 26.47% | 0.68 55.81% | 0.83 20.90% | N/A |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -0.03 61.14% |
| Revenue Q2Q % growth | 38.114M 11.34% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -4.012M 60.74% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.03 82.35% | -0.03 | 0.00 | 11.76% |
| Q2 2024 Q2Q % growth | -0.06 82.86% | -0.04 | -0.02 | -47.06% |
| Q1 2024 Q2Q % growth | -0.02 92.59% | -0.09 | 0.07 | 78.21% |
| Q4 2023 Q2Q % growth | -0.07 58.82% | -0.17 | 0.10 | 58.07% |
| Q3 2023 Q2Q % growth | -0.17 55.26% | -0.30 | 0.13 | 43.02% |
| Q2 2023 Q2Q % growth | -0.35 36.36% | -0.24 | -0.11 | -47.02% |
| Q1 2023 Q2Q % growth | -0.27 57.14% | -0.21 | -0.06 | -30.40% |
| Q4 2022 Q2Q % growth | -0.17 68.52% | -0.29 | 0.12 | 41.52% |
| Q3 2022 Q2Q % growth | -0.38 25.49% | -0.38 | 0.00 | 0.92% |
| Q2 2022 Q2Q % growth | -0.55 11.29% | -0.52 | -0.03 | -6.78% |
| Q1 2022 Q2Q % growth | -0.63 -8.62% | -0.49 | -0.14 | -29.76% |
| Q4 2021 Q2Q % growth | -0.54 20.59% | -0.59 | 0.05 | 8.09% |
| Q3 2021 Q2Q % growth | -0.51 20.31% | -0.62 | 0.11 | 17.76% |
| Q2 2021 Q2Q % growth | -0.62 -1.64% | -0.57 | -0.05 | -9.72% |
| Q1 2021 Q2Q % growth | -0.58 -1.75% | -0.58 | 0.00 | 0.24% |
| Q4 2020 Q2Q % growth | -0.68 -4.62% | -0.66 | -0.02 | -2.56% |
| Q3 2020 Q2Q % growth | -0.64 -52.38% | -0.64 | 0.00 | -0.05% |
| Q2 2020 Q2Q % growth | -0.61 3.17% | -0.65 | 0.04 | 6.47% |
| Q1 2020 Q2Q % growth | -0.57 28.75% | -0.67 | 0.10 | 14.52% |
| Q4 2019 Q2Q % growth | -0.65 -3.17% | -0.57 | -0.08 | -14.23% |
| Q3 2019 Q2Q % growth | -0.42 14.29% | -0.58 | 0.16 | 27.76% |
| Q2 2019 Q2Q % growth | -0.63 -16.67% | -0.66 | 0.03 | 3.94% |
| Q1 2019 Q2Q % growth | -0.80 1.23% | -0.50 | -0.30 | -60.79% |
| Q4 2018 Q2Q % growth | -0.63 | -0.47 | -0.16 | -34.27% |
| Q3 2018 Q2Q % growth | -0.49 | -0.45 | -0.04 | -7.82% |
| Q2 2018 Q2Q % growth | -0.54 | -0.71 | 0.17 | 24.15% |
| Q1 2018 Q2Q % growth | -0.81 | -0.87 | 0.06 | 7.21% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 32.81M 4.38% | 37.672M | -4.862M | -12.91% |
| Q2 2024 Q2Q % growth | 36.024M 13.42% | 36.605M | -581K | -1.59% |
| Q1 2024 Q2Q % growth | 34.67M 17.07% | 33.635M | 1.035M | 3.08% |
| Q4 2023 Q2Q % growth | 34.233M 14.00% | 31.595M | 2.638M | 8.35% |
| Q3 2023 Q2Q % growth | 31.434M 18.35% | 33.303M | -1.869M | -5.61% |
| Q2 2023 Q2Q % growth | 31.762M 14.95% | 32.33M | -568K | -1.76% |
| Q1 2023 Q2Q % growth | 29.615M 26.24% | 30.281M | -666K | -2.20% |
| Q4 2022 Q2Q % growth | 30.03M 45.35% | 27.435M | 2.595M | 9.46% |
| Q3 2022 Q2Q % growth | 26.56M 14.33% | 27.499M | -939K | -3.41% |
| Q2 2022 Q2Q % growth | 27.63M 23.13% | 25.39M | 2.24M | 8.82% |
| Q1 2022 Q2Q % growth | 23.46M 17.18% | 23.058M | 402K | 1.74% |
| Q4 2021 Q2Q % growth | 20.66M 0.24% | 26.104M | -5.444M | -20.86% |
| Q3 2021 Q2Q % growth | 23.23M 16.32% | 26.024M | -2.794M | -10.74% |
| Q2 2021 Q2Q % growth | 22.44M -1.01% | 30.263M | -7.823M | -25.85% |
| Q1 2021 Q2Q % growth | 20.02M -21.18% | 26.243M | -6.223M | -23.71% |
| Q4 2020 Q2Q % growth | 20.61M -41.25% | 19.519M | 1.091M | 5.59% |
| Q3 2020 Q2Q % growth | 19.97M -53.14% | 17.512M | 2.458M | 14.04% |
| Q2 2020 Q2Q % growth | 22.67M -38.16% | 18.04M | 4.63M | 25.67% |
| Q1 2020 Q2Q % growth | 25.4M -19.62% | 21.657M | 3.743M | 17.28% |
| Q4 2019 Q2Q % growth | 35.08M 21.64% | 32.451M | 2.629M | 8.10% |
| Q3 2019 Q2Q % growth | 42.62M 115.36% | 35.246M | 7.374M | 20.92% |
| Q2 2019 Q2Q % growth | 36.66M 112.15% | 32.334M | 4.326M | 13.38% |
| Q1 2019 Q2Q % growth | 31.6M 173.12% | 28.599M | 3.001M | 10.49% |
| Q4 2018 Q2Q % growth | 28.84M | 27.472M | 1.368M | 4.98% |
| Q3 2018 Q2Q % growth | 19.79M | 20.239M | -449K | -2.22% |
| Q2 2018 Q2Q % growth | 17.28M | 13.434M | 3.846M | 28.63% |
| Q1 2018 Q2Q % growth | 11.57M | 11.591M | -21K | -0.18% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 46.66% | -12.12% | -7.24% |
| Revenue | 0% | -9.89% | -5.07% | -4.52% |